Found: 72
Select item for more details and to access through your institution.
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 2, p. 310, doi. 10.1002/ijc.21357
- By:
- Publication type:
- Article
Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
- Published in:
- Genes, Chromosomes & Cancer, 1995, v. 14, n. 3, p. 196, doi. 10.1002/gcc.2870140307
- By:
- Publication type:
- Article
Trans-population Analysis of Genetic Mechanisms of Ethnic Disparities in Neuroblastoma Survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 4, p. 302, doi. 10.1093/jnci/djs503
- By:
- Publication type:
- Article
ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 16, p. 1236, doi. 10.1093/jnci/djr256
- By:
- Publication type:
- Article
MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.
- Published in:
- Oncogene, 2004, v. 23, n. 3, p. 753, doi. 10.1038/sj.onc.1207151
- By:
- Publication type:
- Article
Megadose Methylprednisolone for the Treatment of Myelofibrosis.
- Published in:
- 1992
- By:
- Publication type:
- Letter
Dear Sir:.
- Published in:
- 1991
- By:
- Publication type:
- Letter
Infantile Myelofibrosis with Nephromegaly Secondary to Myeloid Metaplasia.
- Published in:
- Clinical Pediatrics, 1991, v. 30, n. 1, p. 59, doi. 10.1177/000992289103000111
- By:
- Publication type:
- Article
Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus.
- Published in:
- 1988
- By:
- Publication type:
- journal article
The spectrum of metabolic bone disease in lymphoblastic leukemia.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 6, p. 885, doi. 10.1093/jnci/djae062
- By:
- Publication type:
- Article
Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 3, p. 669, doi. 10.1016/j.molonc.2014.01.010
- By:
- Publication type:
- Article
Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 4, p. 541, doi. 10.2967/jnumed.112.112334
- By:
- Publication type:
- Article
Secreted Protein Acidic and Rich in Cysteine Is a Matrix Scavenger Chaperone.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0023880
- By:
- Publication type:
- Article
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi‐site longitudinal survey study.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 7, p. 1101, doi. 10.1002/cncr.35149
- By:
- Publication type:
- Article
Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 15, p. 2967, doi. 10.1002/cncr.34263
- By:
- Publication type:
- Article
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31089
- By:
- Publication type:
- Article
In Memoriam: Sharon B. Murphy, MD (1943–2023).
- Published in:
- 2024
- By:
- Publication type:
- Obituary
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 1, p. 1, doi. 10.1002/pbc.30735
- By:
- Publication type:
- Article
Multimodality treatment for recurrent neuroblastoma in the central nervous system.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 4, p. 1, doi. 10.1002/pbc.30227
- By:
- Publication type:
- Article
Rethinking high‐risk neuroblastoma treatment.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29730
- By:
- Publication type:
- Article
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high‐risk neuroblastoma: An International Neuroblastoma Risk Group project.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28794
- By:
- Publication type:
- Article
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The challenge of defining "ultra-high-risk" neuroblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.
- Published in:
- 2017
- By:
- Publication type:
- case study
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Second malignancies in patients with neuroblastoma: The effects of risk-based therapy.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 1, p. 128, doi. 10.1002/pbc.25249
- By:
- Publication type:
- Article
Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 11, p. 1932, doi. 10.1002/pbc.25134
- By:
- Publication type:
- Article
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 8, p. 1350, doi. 10.1002/pbc.25033
- By:
- Publication type:
- Article
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A report from the Children's Oncology Group (ANBL0621).
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 6, p. 990, doi. 10.1002/pbc.24900
- By:
- Publication type:
- Article
Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 6, p. 1104, doi. 10.1002/pbc.24889
- By:
- Publication type:
- Article
Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 4, p. 627, doi. 10.1002/pbc.24777
- By:
- Publication type:
- Article
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 6, p. 985, doi. 10.1002/pbc.24433
- By:
- Publication type:
- Article
Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 512, doi. 10.1002/pbc.24385
- By:
- Publication type:
- Article
Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 363, doi. 10.1002/pbc.24238
- By:
- Publication type:
- Article
Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 332, doi. 10.1002/pbc.24311
- By:
- Publication type:
- Article
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 642, doi. 10.1002/pbc.24004
- By:
- Publication type:
- Article
Locoregional MYCN-amplified neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 736, doi. 10.1002/pbc.24003
- By:
- Publication type:
- Article
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 7, p. 1099, doi. 10.1002/pbc.24116
- By:
- Publication type:
- Article
Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 3, p. 472, doi. 10.1002/pbc.23131
- By:
- Publication type:
- Article
Protocol for the Examination of Specimens From Patients With Neuroblastoma and Related Neuroblastic Tumors.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2005, v. 129, n. 7, p. 874, doi. 10.5858/2005-129-874-pfteos
- By:
- Publication type:
- Article